2023
DOI: 10.1055/s-0043-1767713
|View full text |Cite
|
Sign up to set email alerts
|

Central Nervous System Neuroimmunologic Complications of COVID-19

Abstract: Autoimmune disorders of the central nervous system following COVID-19 infection include multiple sclerosis (MS), neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune encephalitis, acute disseminated encephalomyelitis, and other less common neuroimmunologic disorders. In general, these disorders are rare and likely represent postinfectious phenomena rather than direct consequences of the SARS-CoV-2 virus itself. The impact of COVID-19 infection on p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 151 publications
(223 reference statements)
0
1
0
Order By: Relevance
“…These SARS-CoV-2–related forms of encephalitis have an estimated overall prevalence of about 2/10,000. In most cases, encephalitis occurs weeks or months after the acute respiratory viral infection and presents as post-infectious autoimmune encephalitis ( Holroyd and Conway, 2023 ). However, encephalitis may also occur in severe cases of COVID-19 pneumonia or multisystem inflammatory syndrome in children (MIS-C) with the inflammation of multiple organs, including the brain ( Olivotto et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…These SARS-CoV-2–related forms of encephalitis have an estimated overall prevalence of about 2/10,000. In most cases, encephalitis occurs weeks or months after the acute respiratory viral infection and presents as post-infectious autoimmune encephalitis ( Holroyd and Conway, 2023 ). However, encephalitis may also occur in severe cases of COVID-19 pneumonia or multisystem inflammatory syndrome in children (MIS-C) with the inflammation of multiple organs, including the brain ( Olivotto et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%